These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 30457858)
1. qFit-ligand Reveals Widespread Conformational Heterogeneity of Drug-Like Molecules in X-Ray Electron Density Maps. van Zundert GCP; Hudson BM; de Oliveira SHP; Keedy DA; Fonseca R; Heliou A; Suresh P; Borrelli K; Day T; Fraser JS; van den Bedem H J Med Chem; 2018 Dec; 61(24):11183-11198. PubMed ID: 30457858 [TBL] [Abstract][Full Text] [Related]
2. Computational analysis of BACE1-ligand complex crystal structures and linear discriminant analysis for identification of BACE1 inhibitors with anti P-glycoprotein binding property. Manoharan P; Chennoju K; Ghoshal N J Biomol Struct Dyn; 2018 Jan; 36(1):262-276. PubMed ID: 28081663 [TBL] [Abstract][Full Text] [Related]
3. Expanding Automated Multiconformer Ligand Modeling to Macrocycles and Fragments. Flowers J; Echols N; Correy G; Jaishankar P; Togo T; Renslo AR; van den Bedem H; Fraser JS; Wankowicz SA bioRxiv; 2024 Sep; ():. PubMed ID: 39386683 [TBL] [Abstract][Full Text] [Related]
4. Conformational transition in the substrate binding domain of β-secretase exploited by NMA and its implication in inhibitor recognition: BACE1-myricetin a case study. Chakraborty S; Kumar S; Basu S Neurochem Int; 2011 Jul; 58(8):914-23. PubMed ID: 21354237 [TBL] [Abstract][Full Text] [Related]
5. qFit 3: Protein and ligand multiconformer modeling for X-ray crystallographic and single-particle cryo-EM density maps. Riley BT; Wankowicz SA; de Oliveira SHP; van Zundert GCP; Hogan DW; Fraser JS; Keedy DA; van den Bedem H Protein Sci; 2021 Jan; 30(1):270-285. PubMed ID: 33210433 [TBL] [Abstract][Full Text] [Related]
6. Impact of ligand protonation on virtual screening against beta-secretase (BACE1). Polgar T; Magyar C; Simon I; Keserü GM J Chem Inf Model; 2007; 47(6):2366-73. PubMed ID: 17944457 [TBL] [Abstract][Full Text] [Related]
7. Predicting binding poses and affinity ranking in D3R Grand Challenge using PL-PatchSurfer2.0. Shin WH; Kihara D J Comput Aided Mol Des; 2019 Dec; 33(12):1083-1094. PubMed ID: 31506789 [TBL] [Abstract][Full Text] [Related]
8. Application of fragment screening by X-ray crystallography to beta-secretase. Murray CW; Callaghan O; Chessari G; Cleasby A; Congreve M; Frederickson M; Hartshorn MJ; McMenamin R; Patel S; Wallis N J Med Chem; 2007 Mar; 50(6):1116-23. PubMed ID: 17315856 [TBL] [Abstract][Full Text] [Related]
9. Tyramine fragment binding to BACE-1. Kuglstatter A; Stahl M; Peters JU; Huber W; Stihle M; Schlatter D; Benz J; Ruf A; Roth D; Enderle T; Hennig M Bioorg Med Chem Lett; 2008 Feb; 18(4):1304-7. PubMed ID: 18226904 [TBL] [Abstract][Full Text] [Related]
10. Protein flexibility in virtual screening: the BACE-1 case study. Cosconati S; Marinelli L; Di Leva FS; La Pietra V; De Simone A; Mancini F; Andrisano V; Novellino E; Goodsell DS; Olson AJ J Chem Inf Model; 2012 Oct; 52(10):2697-704. PubMed ID: 23005250 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands. Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843 [TBL] [Abstract][Full Text] [Related]
12. Automated multiconformer model building for X-ray crystallography and cryo-EM. Wankowicz SA; Ravikumar A; Sharma S; Riley B; Raju A; Hogan DW; Flowers J; van den Bedem H; Keedy DA; Fraser JS Elife; 2024 Jun; 12():. PubMed ID: 38904665 [TBL] [Abstract][Full Text] [Related]
13. Conformationally controlled mechanistic aspects of BACE 1 inhibitors. Sonker M; Yadav A Cent Nerv Syst Agents Med Chem; 2012 Mar; 12(1):28-37. PubMed ID: 22280413 [TBL] [Abstract][Full Text] [Related]
14. Potent memapsin 2 (beta-secretase) inhibitors: design, synthesis, protein-ligand X-ray structure, and in vivo evaluation. Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni S; Xu X; Miller HB; Reddy DS; Weerasena V; Turner R; Chang W; Koelsch G; Tang J Bioorg Med Chem Lett; 2008 Feb; 18(3):1031-6. PubMed ID: 18180160 [TBL] [Abstract][Full Text] [Related]
15. Exposing Hidden Alternative Backbone Conformations in X-ray Crystallography Using qFit. Keedy DA; Fraser JS; van den Bedem H PLoS Comput Biol; 2015 Oct; 11(10):e1004507. PubMed ID: 26506617 [TBL] [Abstract][Full Text] [Related]
16. Pyridinyl aminohydantoins as small molecule BACE1 inhibitors. Zhou P; Li Y; Fan Y; Wang Z; Chopra R; Olland A; Hu Y; Magolda RL; Pangalos M; Reinhart PH; Turner MJ; Bard J; Malamas MS; Robichaud AJ Bioorg Med Chem Lett; 2010 Apr; 20(7):2326-9. PubMed ID: 20202842 [TBL] [Abstract][Full Text] [Related]
17. Ligand retargeting by binding site analogy. Wiedmer L; Schärer C; Spiliotopoulos D; Hürzeler M; Śledź P; Caflisch A Eur J Med Chem; 2019 Aug; 175():107-113. PubMed ID: 31077996 [TBL] [Abstract][Full Text] [Related]
18. Encompassing receptor flexibility in virtual screening using ensemble docking-based hybrid QSAR: discovery of novel phytochemicals for BACE1 inhibition. Chakraborty S; Ramachandran B; Basu S Mol Biosyst; 2014 Oct; 10(10):2684-92. PubMed ID: 25088750 [TBL] [Abstract][Full Text] [Related]
19. A PM7 dynamic residue-ligand interactions energy landscape of the BACE1 inhibitory pathway by hydroxyethylamine compounds. Part I: The flap closure process. Gueto-Tettay C; Martinez-Consuegra A; Zuchniarz J; Gueto-Tettay LR; Drosos-Ramírez JC J Mol Graph Model; 2017 Sep; 76():274-288. PubMed ID: 28746905 [TBL] [Abstract][Full Text] [Related]
20. Structure-Based Survey of the Binding Modes of BACE1 Inhibitors. Hu H; Chen Z; Xu X; Xu Y ACS Chem Neurosci; 2019 Feb; 10(2):880-889. PubMed ID: 30540177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]